Li ZUO, MD

Nephrologist

  • Professor of Medicine, Chief of Renal Division, Peking University People’s Hospital
  • President of Chinese Society of Blood Purification Administration

Jonathan BARRATT, PhD, FRCP

Nephrologist

  • Leader of Renal Research Group within the College of Life Sciences, University of Leicester
  • He is the IgA nephropathy Rare Disease Group lead for the UK National Registry of Rare Kidney Diseases (RaDaR) and a member of the steering committee for the International IgA Nephropathy Network
  • Member of the FDA and American Society of Nephrology Kidney Health Initiative: Identifying Surrogate Endpoints for Clinical Trials in IgA Nephropathy Work group
  • Editorial Board member for Kidney International and Clinical Journal of the American Society of Nephrology
  • Co-Chair of the UK Glomerulonephritis Clinical Study Group and IgA nephropathy lead for the recent revision of the KDIGO Clinical Practice Guidelines for Glomerular Diseases

Johan ROSMAN, MD, PhD, FRACP

Nephrologist

  • Foundation Professor of Medicine, Curtin University Medical School, Australia
  • Active on several editorial boards and review committees and author of about 100 publications in peer-reviewed journals and book chapters

Ling SU, PhD

Regulatory

  • An epidemiologist and drug development professional with 25 years of industry and government experience in the US and Asia
  • He had held various research and managementpositions at Merck, Roche, Wyeth/Pfizer, Norvatis . His extensive experience spans the fields of regulatory affairs, medicinal product development strategy, clinical research, drug safety, and pharmacoepidemiology
  • He served as the DIA board President in 2012

Steve LANDAU, MD

Business Development

  • Dr. Landau has been in the biotechnology field for more than 20 years and is currently a Consultant in the health care field
  • He is a Senior Consultant to Ocumension (since 2017), a leading Ophthalmic Company in China
  • He was Founder and a Consulting Chief of Development for Convelo Therapeutics, focused on re-myelination, which in 2019 completed a collaboration and option to acquire agreement with Genentech/Roche Group
  • He is a summa cum laude graduate of Bowdoin College and a member of Phi Beta Kappa
  • He earned his MD from Case Western Reserve University in Cleveland Ohio graduating as a member of Alpha Omega Alpha